Jazz Pharmaceuticals plc
US ˙ NasdaqGS ˙ IE00B4Q5ZN47

SecurityJAZZ / Jazz Pharmaceuticals plc
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in JAZZ / Jazz Pharmaceuticals plc

On August 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of Jazz Pharmaceuticals plc (US:JAZZ) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR on May 15, 2025 disclosing 34,179 shares of Jazz Pharmaceuticals plc. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-14 2025-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -100.00 0
2025-05-15 2025-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 34,179 -4,364 -11.32 4,243 -10.60 0.0139
2025-02-14 2024-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 38,543 38,543 4,747 0.0144
2024-07-16 2023-12-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 0 -12,714 -100.00 0 -100.00
2024-02-14 2023-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -12,714 0
2023-11-14 2023-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 12,714 -17,263 -57.59 1,646 -55.73 0.0058
2023-08-14 2023-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 29,977 -1,615 -5.11 3,716 -19.60 0.0123
2023-05-15 2023-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 31,592 2,248 7.66 4,623 -1.11 0.0159
2023-02-14 2022-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 29,344 -2,473 -7.77 4,675 10.24 0.0169
2023-02-14 2022-09-30 13F/A-1 Jazz Pharmaceuticals SHS USD G50871105 31,817 -6,297 -16.52 4,241 -28.69 0.0167
2022-11-14 2022-09-30 13F Jazz Pharmaceuticals SHS USD G50871105 31,817 -6,297 4,240 0.0167
2023-02-14 2022-06-30 13F/A-1 Jazz Pharmaceuticals SHS USD G50871105 38,114 -13,598 -26.30 5,946 -26.14 0.0220
2022-08-15 2022-06-30 13F Jazz Pharmaceuticals SHS USD G50871105 38,114 -13,598 5,947 0.0220
2023-02-14 2022-03-31 13F/A-1 Jazz Pharmaceuticals SHS USD G50871105 51,712 -110,815 -68.18 8,050 -61.12 0.0229
2022-05-13 2022-03-31 13F Jazz Pharmaceuticals SHS USD G50871105 51,712 -110,815 8,050 0.0229
2022-02-14 2021-12-31 13F Jazz Pharmaceuticals SHS USD G50871105 162,527 -69,198 -29.86 20,707 -31.37 0.0529
2021-11-15 2021-09-30 13F Jazz Pharmaceuticals SHS USD G50871105 231,725 14,538 6.69 30,173 -21.79 0.0847
2021-08-13 2021-06-30 13F/A-1 Jazz Pharmaceuticals SHS USD G50871105 217,187 25,774 13.47 38,581 22.63 0.1088
2021-08-13 2021-06-30 13F Jazz Pharmaceuticals SHS USD G50871105 217,187 25,774 38,581 0.0651
2021-05-14 2021-03-31 13F Jazz Pharmaceuticals SHS USD G50871105 191,413 27,527 16.80 31,462 16.31 0.0958
2021-02-12 2020-12-31 13F Jazz Pharmaceuticals SHS USD G50871105 163,886 -1,968 -1.19 27,049 14.38 0.0849
2021-02-11 2020-09-30 13F/A-1 Jazz Pharmaceuticals SHS USD G50871105 165,854 -5,634 -3.29 23,649 24.98 0.0855
2020-11-13 2020-09-30 13F Jazz Pharmaceuticals SHS USD G50871105 165,854 -5,634 23,649 47,207.1574
2021-02-12 2020-06-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 171,488 10,261 6.36 18,922 17.67 0.0745
2020-08-14 2020-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 171,488 10,261 18,922 74,621.6683
2021-02-12 2020-03-31 13F/A-2 JAZZ PHARMACEUTICALS SHS USD G50871105 161,227 8,461 5.54 16,081 -29.48 0.0804
2020-06-15 2020-03-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 161,227 0 16,081 0.0804
2020-05-15 2020-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 161,227 8,461 16,081 44,721.5376
2021-02-12 2019-12-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 152,766 693 0.46 22,804 17.02 0.0927
2020-02-18 2019-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 152,766 693 22,804 92,850.0910
2021-02-12 2019-09-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 152,073 -20,597 -11.93 19,487 -20.84 0.0775
2019-11-14 2019-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 152,073 -20,597 19,487 77,656.9356
2021-02-12 2019-06-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 172,670 -24,287 -12.33 24,616 -12.57 0.0961
2019-08-13 2019-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 172,670 -24,287 24,616 96,533.5983
2019-05-14 2019-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 196,957 10,703 5.75 28,155 21.95 0.1100
2019-02-13 2018-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 186,254 34,225 22.51 23,088 -9.67 0.1006
2018-11-08 2018-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 152,029 1,669 1.11 25,560 -1.34 0.0937
2018-08-13 2018-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 150,360 51,169 51.59 25,907 72.98 0.0993
2018-05-14 2018-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 99,191 11,222 12.76 14,977 26.44 0.0598
2018-02-13 2017-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 87,969 -28,893 -24.72 11,845 -30.69 0.0465
2017-12-01 2017-09-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 116,862 22,007 23.20 17,091 15.87 0.0736
2017-11-13 2017-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 116,862 22,007 17,091
2017-08-10 2017-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 94,855 63,155 199.23 14,750 220.58 0.0670
2017-05-11 2017-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 31,700 -28,000 -46.90 4,601 -29.31 0.0208
2017-02-13 2016-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 59,700 -2,500 -4.02 6,509 -13.86 0.0305
2016-11-10 2016-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 62,200 -300 -0.48 7,556 -14.45 0.0332
2016-08-11 2016-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 62,500 16,000 34.41 8,832 45.48 0.0393
2016-05-13 2016-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 46,500 -25,500 -35.42 6,071 -40.01 0.0272
2016-02-12 2015-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 72,000 300 0.42 10,120 6.28 0.0442
2015-11-13 2015-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 71,700 -38,081 -34.69 9,522 -50.74 0.0390
2015-08-13 2015-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 109,781 -72,419 -39.75 19,329 -38.60 0.0774
2015-05-13 2015-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 182,200 4,854 2.74 31,482 8.42 0.1297
2015-02-13 2014-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 177,346 1,586 0.90 29,037 2.90 0.1165
2014-11-13 2014-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 175,760 28,406 19.28 28,220 30.27 0.1206
2014-08-13 2014-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 147,354 -2,642 -1.76 21,663 4.14 0.0901
2014-05-13 2014-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 149,996 -53,454 -26.27 20,801 -19.22 0.0905
2014-02-13 2013-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 203,450 -22,451 -9.94 25,749 23.94 0.1153
2013-11-13 2013-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 225,901 -103,974 -31.52 20,776 -8.36 0.1023
2013-08-12 2013-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 329,875 329,875 22,672 0.1204
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.